Anaplastic thyroid cancer

2 trials 1 recruiting MedDRA PT
2 Registered trials
1 Recruiting
2 Unique sponsors
5 Unique IMPs
0 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
L Oncology (ATC L) 1
V Various (ATC V) 1
Mechanism of action (INN-stem analysis)
Monoclonal antibody (immune) 2 substances
Antimetabolite 1 substance
Supportive / rescue 1 substance
Platinum compound 1 substance
Phase II: 1 Phase I: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase II

1 trial
  • Hospices Civils De Lyon Academic
    DOMVANALIMAB; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; ZIMBERELIMAB
    2024-517254-99-00 1 country 2025 n=186
    Halted

Phase I

1 trial
  • Karolinska University Hospital Academic
    IMP not specified
    2023-508126-95-00 1 country 2025 n=30
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Karolinska University Hospital Academic 1 Phase I 1
Hospices Civils De Lyon Academic 1 Phase II 0
New trials by year
2025
2
← All indication landscapes